Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Showing 20 of 0 results

Not applicableStudy completedNCT04197037
What this trial is testing

Prevalence of Sialorrhea in Patients Treated With Clozapine

Who this might be right for
SialorrheaClozapine Adverse ReactionQuality of Life
Parc de Salut Mar 129
Not applicableUnknownNCT02665611
What this trial is testing

Remote Monitoring and Support for Patients With Schizophrenia, Schizoaffective or Bipolar Disorder on Adherence

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
Assuta Hospital Systems 300
Testing effectiveness (Phase 2)Study completedNCT04461119
What this trial is testing

Study to Determine the Safety, Tolerability, and Efficacy of Evenamide in Patients With Chronic Schizophrenia

Who this might be right for
Schizophrenia
Newron Pharmaceuticals SPA 138
Post-approval studies (Phase 4)Not Yet RecruitingNCT03575000
What this trial is testing

Bromocriptine for Patients With Schizophrenia and Prediabetes

Who this might be right for
SchizophreniaPreDiabetes
VA Pittsburgh Healthcare System 15
Not applicableStudy completedNCT00823199
What this trial is testing

An Open Trial of Allopurinol in Patients With Poorly Responsive Schizophrenia

Who this might be right for
Schizophrenia
Bronx Psychiatric Center 10
Large-scale testing (Phase 3)Study completedNCT02335658
What this trial is testing

Long-term Study of DSP-5423P in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Sumitomo Pharma Co., Ltd. 200
Large-scale testing (Phase 3)Study completedNCT00249132
What this trial is testing

The Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen, LP 523
Large-scale testing (Phase 3)Study completedNCT00297947
What this trial is testing

High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Manhattan Psychiatric Center 60
Large-scale testing (Phase 3)UnknownNCT02453893
What this trial is testing

Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia

Who this might be right for
Schizophrenia
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 288
Early research (Phase 1)Ended earlyNCT00929370
What this trial is testing

A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.

Who this might be right for
Schizophrenia
GlaxoSmithKline 34
Not applicableUnknownNCT00825045
What this trial is testing

Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
Centre for Addiction and Mental Health 14
Testing effectiveness (Phase 2)Study completedNCT01649557
What this trial is testing

Multicenter, Open-label, Safety and Tolerability Study

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 244
Large-scale testing (Phase 3)Study completedNCT01626872
What this trial is testing

Long-Term Study of MP-214 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Tanabe Pharma Corporation 254
Not applicableStudy completedNCT05936983
What this trial is testing

Comparison of Physical Fitness, Physical Activity Level in Patients With Bipolar Disorder and Schizophrenia

Who this might be right for
Bipolar DisorderSchizophrenia
Yeditepe University 90
Testing effectiveness (Phase 2)Looking for participantsNCT06821945
What this trial is testing

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Boryung Pharmaceutical Co., Ltd 120
Not applicableActive Not RecruitingNCT06474195
What this trial is testing

Cue-based Intervention in Prospective Memory and Medication Adherence.

Who this might be right for
Schizophrenia
University of Pittsburgh 104
Not applicableStudy completedNCT01793324
What this trial is testing

EMR Data to Assess Monitoring of Patients Treated With Quetiapine

Who this might be right for
SchizophreniaBipolar DisorderMajor Depressive Disorder
AstraZeneca 6,153
Large-scale testing (Phase 3)Study completedNCT01129882
What this trial is testing

An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 709
Large-scale testing (Phase 3)Ended earlyNCT00637494
What this trial is testing

Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Who this might be right for
Psychotic DepressionSevere Major Depression With Psychotic FeaturesPsychosis
Corcept Therapeutics 292
Testing effectiveness (Phase 2)Study completedNCT00314639
What this trial is testing

Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia

Who this might be right for
Schizophrenia and Schizophrenia Spectrum Psychosis
Laval University 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation